Denosumab (anti-RANK ligand)

Synonyms: AMG-162, Prolia, Xgeva

Denosumab (anti-RANK ligand) (AMG-162, Prolia, Xgeva) is a fully human monoclonal antibody that selectively inhibits primate RANKL. Denosumab inhibits the ability of human RANKL (143–317) to stimulate the formation of osteoclasts derived from murine RAW 264.7 cells with an IC50 value of 1.64 nM.

Denosumab (anti-RANK ligand)

Click to purchase the isotype control of Denosumab (anti-RANK ligand)

Selleck's Denosumab (anti-RANK ligand) has been cited by 1 Publication

Purity & Quality Control

Batch: Purity: 99.68% Protein concentration: 5mg/ml Endotoxin Level: <1EU/mg
99.68

Choose Selective NF-κB Inhibitors

Biological Activity

Description Denosumab (anti-RANK ligand) (AMG-162, Prolia, Xgeva) is a fully human monoclonal antibody that selectively inhibits primate RANKL. Denosumab inhibits the ability of human RANKL (143–317) to stimulate the formation of osteoclasts derived from murine RAW 264.7 cells with an IC50 value of 1.64 nM.

Product Details

CAS No. 615258-40-7
Isotype human IgG4
Source HEK293
Formulation PBS Buffer, pH 7.4
Storage
(From the date of receipt)
Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Denosumab (anti-RANK ligand) | Denosumab (anti-RANK ligand) supplier | purchase Denosumab (anti-RANK ligand) | Denosumab (anti-RANK ligand) cost | Denosumab (anti-RANK ligand) manufacturer | order Denosumab (anti-RANK ligand) | Denosumab (anti-RANK ligand) distributor